Two cases of extragonadal malignant transformation of endometriosis after TAH/BSO for benign indications.

Autor:	Eurich KE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States., Goff BA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States., Urban RR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.; Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, United States.
Jazyk:	angličtina
Zdroj:	Gynecologic oncology reports [Gynecol Oncol Rep] 2019 Jan 04; Vol. 28, pp. 23-25. Date of Electronic Publication: 2019 Jan 04 (Print Publication: 2019).
DOI:	10.1016/j.gore.2018.12.011
Abstrakt:	•Extragonadal malignant transformation of endometriosis can occur after oophorectomy.•Endometriosis-associated malignancy can occur in the absence of hormone replacement.•Estrogen and progesterone receptor status can influence treatment strategies.•The role of chemotherapy for malignant transformation of endometriosis is not clear.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu